logo
Specificity of bioanalytical methods for pharmacokinetic support of biological macromolecular therapeutics is important
Ligand-binding assays: old challenges, new solutions
Obama budget aims to lower biologics exclusivity period
New solid-phase microextraction methodology incorporates LC–MS for untargeted metabolomic profiling
Blood cell analysis could be possible from a simple finger prick test
New LC–MS application for doping controls: determination of growth hormone-releasing peptides
US government funds US$1 billion drug development center
Symposium Report: The Waters Bioanalysis World Tour: The Broadening Impact and Future of the DMPK Laboratory – Addressing Large-Molecule Therapeutics
2011 Bioanalysis Young Investigator Award
Young Investigator: Michelle J Yoo
Regulatory considerations for development of bioanalytical assays for biotechnology products
Comparison of an antibody capture and a cell capture ligand-binding assay to quantify a monoclonal therapeutic in serum
Bioanalytical considerations in the comparability assessment of biotherapeutics
Biotherapeutic bioanalysis: a multi-indication case study review
Peptide and protein drug analysis by MS: challenges and opportunities for the discovery environment
PK–PD modeling of protein drugs: implications in assay development
Challenges in developing bioanalytical assays for characterization of antibody–drug conjugates
Acknowledgements